pennystocksupdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 01/22/2014 -- Orexigen Therapeutics, Inc. (NASDAQ:OREX) is +0.06 - +0.88% from the previous close of $6.81. It traded between $6.70 - 7.03 with total traded volume of 2950383 shares. At Current Market Price, OREX is in distance of +16.50% from its 50-day Moving Average price of $5.897 and +10.58% from its 200-day Moving Average price of $6.2126. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
How Should Investors Trade OREX Now? Find Out Here
Shares of Athersys, Inc. (NASDAQ:ATHX) are trading at $4.17 and is +50.72% from its 50-day Moving Average price of $2.7667 and +109.97% from its 200-day Moving Average price of $1.986. The average trading volume is 1412460 shares and its market capitalization is $251.1M. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
Is ATHX a Solid Investment at These Levels? Find Out Here
Aastrom Biosciences Inc (NASDAQ:ASTM) is very active today and traded between $3.83 - 4.00 with total traded volume of 247700 shares. At a current price of 3.91, ASTM is +0.14 - +3.71% from the previous close of $3.77. Moreover, At Current Market Price, ASTM is in distance of +9.29% from its 50-day Moving Average price of $3.5775 and -33.39% from its 200-day Moving Average price of $5.8699. Aastrom Biosciences, Inc. is a development-stage company. The Company is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. The Company is developing patient-specific, expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases.
Is ASTM Showing Any Sign of Buy At The Current Market Price? Find Out Here
Tengion, Inc. (OTCMKTS:TNGN) is +0.01 - +4.55% from the previous close of $0.22. It traded between $0.215 - 0.24 with total traded volume of 591319 shares. Keep a close eye on TNGN, as the stock has been showing unusual moves over the past weeks. At Current market price, TNGN has recovered +15.00% from its 52-week Low of 0.20 and has Pulled back -84.56% from its 52-week high of 1.49. Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company focuses on creating these functional neo-organs and neo-tissues using a patient’s own cells, or autologous cells, in conjunction with its Organ Regeneration Platform.
Can TNGN Extend Gain? If Yes, How Far It Can Go? Find Out Here
United Therapeutics Corporation (NASDAQ:UTHR) reported EPS of 5.503. For the Current Fiscal year, the company is expected to report EPS of 5.42. For the Next Quarter and Next Year, the company is expected to report EPS of 1.65 and 7.23 respectively. At Current Market Price, UTHR is in distance of +10.97% from its 50-day Moving Average price of $102.18 and +33.66% from its 200-day Moving Average price of $84.8326. United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
What Should Investors Do With UTHR Now? Find Out Here
Neither Pennystocksupdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Adviser or broker dealer in any jurisdiction whatsoever and none of the information provided by Pennystocksupdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. Pennystocksupdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Pennystocksupdate.biz . Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein.
Read full disclaimer: http://www.pennystocksupdate.biz/disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)